249 related articles for article (PubMed ID: 25965346)
1. SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation.
Yang L; Carrillo M; Wu YM; DiAngelo SL; Silveyra P; Umstead TM; Halstead ES; Davies ML; Hu S; Floros J; McCormack FX; Christensen ND; Chroneos ZC
PLoS One; 2015; 10(5):e0126576. PubMed ID: 25965346
[TBL] [Abstract][Full Text] [Related]
2. SP-R210 isoforms of Myosin18A modulate endosomal sorting and recognition of influenza A virus infection in macrophages.
Yau E; Yang L; Chen Y; Umstead TM; Stanley AE; Halstead ES; Gandhi CK; Yewdell JW; Chroneos ZC
Microbes Infect; 2024; 26(3):105280. PubMed ID: 38135024
[TBL] [Abstract][Full Text] [Related]
3. Genomic and epigenomic adaptation in SP-R210 (Myo18A) isoform-deficient macrophages.
Yau E; Chen Y; Song C; Webb J; Carillo M; Kawasawa YI; Tang Z; Takahashi Y; Umstead TM; Dovat S; Chroneos ZC
Immunobiology; 2021 Nov; 226(6):152150. PubMed ID: 34735924
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.
Sever-Chroneos Z; Krupa A; Davis J; Hasan M; Yang CH; Szeliga J; Herrmann M; Hussain M; Geisbrecht BV; Kobzik L; Chroneos ZC
J Biol Chem; 2011 Feb; 286(6):4854-70. PubMed ID: 21123169
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the SP-A/SP-R210
Guan Z; Worth B; Umstead TM; Amatya S; Booth J; Chroneos ZC
Am J Physiol Lung Cell Mol Physiol; 2024 Apr; 326(4):L508-L513. PubMed ID: 38349123
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway.
Alcorn JF; Wright JR
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L129-36. PubMed ID: 12959932
[TBL] [Abstract][Full Text] [Related]
7. Surfactant Proteins A/D-CD14 on Alveolar Macrophages Is a Common Pathway Associated With Phagocytosis of Nanomaterials and Cytokine Production.
Wang Q; Wang Q; Zhao Z; Fan J; Qin L; Alexander DB; Tsuda H; Zhao D; Xu J
Front Immunol; 2021; 12():758941. PubMed ID: 34777371
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein-D regulates soluble CD14 through matrix metalloproteinase-12.
Senft AP; Korfhagen TR; Whitsett JA; Shapiro SD; LeVine AM
J Immunol; 2005 Apr; 174(8):4953-9. PubMed ID: 15814723
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory function of SP-A.
Dong S; Pang H; Li F; Hua M; Liang M; Song C
Mol Immunol; 2024 Feb; 166():58-64. PubMed ID: 38244369
[TBL] [Abstract][Full Text] [Related]
10. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha.
Janssen WJ; McPhillips KA; Dickinson MG; Linderman DJ; Morimoto K; Xiao YQ; Oldham KM; Vandivier RW; Henson PM; Gardai SJ
Am J Respir Crit Care Med; 2008 Jul; 178(2):158-67. PubMed ID: 18420961
[TBL] [Abstract][Full Text] [Related]
11. Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/toll-like receptor 4, and is inhibited by surfactant protein D.
Liu CF; Chen YL; Chang WT; Shieh CC; Yu CK; Reid KB; Wang JY
Clin Exp Allergy; 2005 Dec; 35(12):1615-24. PubMed ID: 16393328
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A.
Kuronuma K; Sano H; Kato K; Kudo K; Hyakushima N; Yokota S; Takahashi H; Fujii N; Suzuki H; Kodama T; Abe S; Kuroki Y
J Biol Chem; 2004 May; 279(20):21421-30. PubMed ID: 14993215
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages.
Beharka AA; Gaynor CD; Kang BK; Voelker DR; McCormack FX; Schlesinger LS
J Immunol; 2002 Oct; 169(7):3565-73. PubMed ID: 12244146
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
Sano H; Sohma H; Muta T; Nomura S; Voelker DR; Kuroki Y
J Immunol; 1999 Jul; 163(1):387-95. PubMed ID: 10384140
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein A modulates cell surface expression of CR3 on alveolar macrophages and enhances CR3-mediated phagocytosis.
Gil M; McCormack FX; Levine AM
J Biol Chem; 2009 Mar; 284(12):7495-504. PubMed ID: 19155216
[TBL] [Abstract][Full Text] [Related]
16. The Role of Collectins and Galectins in Lung Innate Immune Defense.
Casals C; Campanero-Rhodes MA; García-Fojeda B; Solís D
Front Immunol; 2018; 9():1998. PubMed ID: 30233589
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils.
Schagat TL; Wofford JA; Wright JR
J Immunol; 2001 Feb; 166(4):2727-33. PubMed ID: 11160338
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity.
Chiba H; Piboonpocanun S; Mitsuzawa H; Kuronuma K; Murphy RC; Voelker DR
Respirology; 2006 Jan; 11 Suppl():S2-6. PubMed ID: 16423264
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
Gaynor CD; McCormack FX; Voelker DR; McGowan SE; Schlesinger LS
J Immunol; 1995 Dec; 155(11):5343-51. PubMed ID: 7594549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
